Managing nonmalignant chronic abdominal pain and malignant bowel obstruction

Gastroenterology Clinics of North America

Volumn 35, Issue 1, 2006, Pages 131-142

  Bicanovsky, Lesley K ^a   Lagman, Ruth L ^a   Davis, Mellar P ^a   Walsh, Declan ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; ANALGESIC AGENT; CORTICOSTEROID; GLYCOPYRRONIUM BROMIDE; HALOPERIDOL; HISTAMINE H2 RECEPTOR ANTAGONIST; KETOROLAC; LOPERAMIDE; METOCLOPRAMIDE; MORPHINE; OCTREOTIDE; OPIATE; SEROTONIN 3 RECEPTOR;

ABDOMINAL PAIN; BILE DUCT OBSTRUCTION; CHRONIC PANCREATITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; HUMAN; INTESTINE OBSTRUCTION; MORBIDITY; NAUSEA; PANCREAS DUCT STENOSIS; PREVALENCE; REVIEW; STOMACH PARESIS; THORACOSCOPY; ULTRASOUND; VOMITING;

ABDOMINAL PAIN; CHRONIC DISEASE; HUMANS; INTESTINAL NEOPLASMS; INTESTINAL OBSTRUCTION;

EID: 33644842569     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2006.01.002     Document Type: Review

References (88)

1. R.C. Heading Prevalence of upper gastrointestinal symptoms in the general population: a systematic review Scand J Gastroenterol Suppl 231 1999 3
2. R. Jones, and S. Lydeard Irritable bowel syndrome in the general population BMJ 304 1992 87
3. R. Sandler Epidemiology of irritable bowel syndrome in the United States Gastroenterology 99 1993 409
4. A.B. Fleischer Jr., E.F. Gardner, and S.R. Feldman Are patients. Chief complaints generally specific to one organ system? Am J Manag Care 7 2001 299
5. R.A. Kamin, T.A. Nowicki, and D.S. Courtney Pearls and pitfalls in the emergency department evaluation of abdominal pain Emerg Med Clin North Am 21 1 2003 10
6. Y.K. Choi, and S. Chou Rectus syndrome. Another cause of upper abdominal pain Reg Anesth 20 4 1995 347 351
7. F. Cervero Visceral pain - central sensitization Gut 47 Suppl 4 2000 56 57
8. M.A. Giamberardino Recent and forgotten aspects of visceral pain Eur J Pain 3 1999 77 92
9. A.R. Hobson, and Q. Aziz Central nervous system processing of human visceral pain in health and disease News Physiol Sci 18 2003 109 114
10. F. Cervero Visceral hyperalgesia revisited Lancet 356 9236 2000 1127 1128
11. G.F. Gebhart Pathobiology of visceral pain: molecular mechanisms and therapeutic implications v. central nervous system processing of somatic and visceral sensory signals Am J Physiol Gastrointest Liver Physiol 278 6 2000 G834 G838
12. F. Cervero Neurophysiology of gastrointestinal pain Baillieres Clin Gastroenterol 2 1988 183
13. P. Haupt, W. Janig, and W. Kohler Response pattern of visceral afferent fibers, supplying the colon upon chemical and mechanical stimuli Pflugers Arch 398 1983 41
14. F. Cervero Sensory innervation of the viscera: peripheral basis of visceral pain Physiol Rev 7 1 1994 95 138
15. G.F. Gebhart Visceral nociception: consequences, modulation, and the future Eur J Anaesthesiol Suppl 10 1995 24 27
16. S.B. McMahon Are there fundamental differences in the peripheral mechanisms of visceral and somatic pain? Behav Brain Sci 20 1997 381 391
17. M.L. Steer, I. Waxman, and S.D. Freedman Chronic pancreatitis N Engl J Med 332 1995 1482
18. I. Ihse, R. Andersson, and N. Albiin Guidelines for management of patients with chronic pancreatitis. Report from a consensus conference Lakartidningen 100 2003 2518 2525
19. K. Mergener, and J. Baillie Chronic pancreatitis Lancet 350 1997 1379
20. M.A. Chung, C. Oung, and A. Szilagyi Cullen's sign: it doesn't always mean hemorrhagic pancreatitis Am J Gastroenterol 87 8 1992 1026 1028
21. Toskes PP. Gastroenterology and hepatology: the comprehensive visual reference. Volume 8, pancreas. In: Feldman M, editor. Gastroenterology and hepatology: the comprehensive visual reference series. Current Medicine, Incorporated; 1998. p. 1.4-1.5.
22. Lee MJ, Mueller PR, van Sonnenberg E, et al. CT-guided celiac ganglion block with alcohol. Am J Radiology 161(9): 633-6.
23. P. Draganov, and P.P. Toskes Chronic pancreatitis: controversies in etiology, diagnosis and treatment Rev Esp Enferm Dig 96 9 2004 649 654
24. P.C. Bornman, I.N. Marks, and A.W. Girdwood Pathogenesis of pain in chronic pancreatitis: ongoing enigma World J Surg 27 11 2003 1175 1182
25. G.W. Hanks, F. Conno, and N. Cherng Morphine and alternative opioids in cancer pain: the EAPC recommendations Br J Cancer 84 2001 587 593
26. K.S. Latta, B. Ginsberg, and R.L. Barkin Meperidine: a critical review Am J Ther 9 2002 53 68
27. R.G. Twycross Therapeutic equivalence of oral and subcutaneous intramuscular morphine sulfate in cancer patients J Palliat Care 2 1988 67 68
28. R.W. Houde, S. Wallenstein, and W.T. Beaver Clinical measurement of pain G. Stevens Analgesics 1965 Academic Press New York 75 122
29. V.V. Singh, and P.P. Toskes Medical therapy for chronic pancreatitis pain Curr Gastroenterol Rep 5 2 2003 110 116
30. J.C. Shea, M.D. Bishop, and E.M. Parker An enteral therapy containing medium-chain triglycerides and hydrolyzed peptides reduces postprandial pain associated with chronic pancreatitis Pancreatology 3 1 2003 36 40
31. J. Mayerle, P. Simon, and M.M. Lerch Medical treatment of acute pancreatitis Gastroenterol Clin North Am 33 4 2004 855 869
32. J.P. Duffy, and H.A. Reber Surgical treatment of chronic pancreatitis J Hepatobiliary Pancreat Surg 9 6 2002 659 668
33. C.P. Morrison, S.A. Wemyss-Holden, and C. Partensky Surgical management of intractable pain in chronic pancreatitis: past and present J Hepatobiliary Pancreat Surg 9 6 2002 675 682
34. M. Hartel, A.A. Tempia-Caliera, and M.N. Wente Evidence-based surgery in chronic pancreatitis Langenbecks Arch Surg 388 2 2003 132 139
35. P. Dite, M. Ruzicka, and V. Zboril A prospective, randomized trial comparing endoscopic and surgical therapy for chronic pancreatitis Curr Gastroenterol Rep 35 7 2004 553 558
36. J. Mossner, and V. Keim Therapy of chronic pancreatitis Internist (Berl) 44 12 2003 1515 1523
37. N.J. Talley, A.R. Zinsmeister, and C. Van Dyke Epidemiology of colonic symptoms and the irritable bowel syndrome Gastroenterology 101 1991 927
38. L.J. Brandt, D. Bjorkman, and M.B. Fennerty Systematic review on the management of irritable bowel syndrome in North America Am J Gastroenterol 97 2002 S7
39. D.A. Drossman, L. Zhiming, and E. Andruzzi US householders survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact Dig Dis Sci 93 1993 1569
40. F. DePonti, and J. Malagegelada Functional gut disorders from motility to sensitivity disorders Pharmacol Ther 89 1998 49 88
41. R.B. Lynn, and L.S. Friedman Irritable bowel syndrome N Engl J Med 329 1993 1940
42. E.T. Swarbrick, L. Bat, and J.E. Hegarty Site of pain from irritable bowel Lancet 2 1980 443
43. D.A. Drossman, and W.G. Thompson The Irritable bowel syndrome: Review and a graduated multicomponent treatment approach Ann Intern Med 116 1992 1009
44. A.O. Quartero, V. Meineche-Schmidt, and J. Muris Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome Cochrane Collaboration 18 2005 CD003460
45. S.J. Eisendrath, and K.T. Kodama Fluoxetine management of chronic abdominal pain Psychosomatics 33 1992 227
46. S.R. Hameroff, J.L. Weiss, and J.C. Lerman Doxepin's effects on chronic pain and depression: A controlled study J Clin Psychiatry 45 1984 47
47. K. Pilowsky, and C.G. Barrow A controlled study of psychotherapy and amitriptyline used individually and in combination in the treatment of chronic intractable psychogenic pain Pain 40 1990 3
48. D.A. Gorard, G.W. Libby, and M.J. Farthing Effect of tricyclic antidepressant on small intestinal motility in health and diarrhea predominant irritable bowel syndrome Dig Dis Sci 40 1995 86
49. R.E. Clouse, P.J. Lustman, and R.A. Geisman Antidepressant therapy in 138 patients with irritable bowel syndrome: a five-year clinical experience Aliment Pharmacol Ther 8 1994 409
50. N.J. Talley Evaluation of drug treatment in irritable bowel syndrome Br J Clin Pharmacol 56 4 2003 362 369
51. M.J. Callahan Irritable bowel syndrome neuropharmacology. A review of approved and investigational compounds J Clin Gastroenterol 35 Suppl 1 2002 S58 S67
52. J. Zighelboim, N.J. Talley, and S.F. Phillips Visceral perception in irritable bowel syndrome: Rectal and gastric responses to distention and serotonin type 3 antagonism Dig Dis Sci 40 1995 819
53. A. Prior, and N.W. Read Reduction of rectal sensitivity and post-prandial motility by granisetron, a 5-HT3-receptor antagonist, in patients with irritable bowel syndrome Aliment Pharmacol Ther 7 1993 175
54. C.M. Prather, M. Camilleri, and A.R. Zinsmeister Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome Gastroenterology 118 2000 463
55. S.A. Muller-Lissner, I. Fumagalli, and K.D. Bardhan Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating, and constipation Aliment Pharmacol Ther 15 2001 1655
56. Camilleri M. Tegaserod in the treatment of irritable bowel syndrome. UpToDate; 2004.
57. N.J. Talley Pharmacologic therapy for the irritable bowel syndrome Am J Gastroenterol 98 4 2003 750 758
58. D.M. Eisenberg, R.B. Davis, and S.L. Ettner Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey JAMA 280 18 1998 1569 1575
59. A. Vickers Recent advances: complementary medicine BMJ 321 2000 683 686
60. A. Bensoussan, S.P. Myers, and A.l. Carlton Risks associated with the practice of traditional Chinese medicine: an Australian study Arch Fam Med 9 10 2000 1071 1078
61. H.L. Koh, and S.O. Woo Chinese proprietary medicine in Singapore: regulatory control of toxic heavy metals and undeclared drugs Drug Saf 23 5 2000 351 362
62. D. Melchart, K. Linde, and W. Weidenhammer Liver enzyme elevations in patients treated with traditional Chinese medicine JAMA 282 1 1999 28 29
63. J.J. Galligan Enteric P2X receptors as potential targets for drug treatment of irritable bowel syndrome Br J Pharmacol 141 8 2004 1294 1302
64. D.J. Feuer, K.E. Broadley, and J.H. Shepard Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer Gynecol Oncol 75 1999 313 322
65. M.C. Parker, H. Ellis, and B.J. Morgan Postoperative adhesions: ten-year follow-up of 12,584 patients undergoing lower abdominal surgery Dis Colon Rectum 44 2001 822
66. V. Schneider, and B. Smyczek Sister Mary Joseph's nodule. Diagnosis of umbilical metastases by fine needle aspiration Acta Cytol 34 4 1990 555 558
67. A.J. Khan, and B. Cook Metastatic carcinoma of umbilicus: Sister Mary Joseph's nodule Cutis 60 6 1997 297 298
68. D.M. Coll, J.M. Meyer, and M. Mader Imaging appearances of Sister Mary Joseph nodule Br J Radiol 72 864 1999 1230 1233
69. G. Blumer Classic articles in colonic and rectal surgery: the rectal shelf Dis Colon Rectum 23 6 1980 445 448
70. N.C. Davis Intestinal succussion splash - a valuable clinical sign insufficiently appreciated Med J Aust 10 1964 360 361
71. E.J. Balthazar CT of small-bowel obstruction AJR Am J Roentgenol 162 1994 255 261
72. J.T. Dunn, J.M. Halls, and T.V. Berne Roentgenographic contrast studies in acute small-bowel obstruction Arch Surg 119 1984 1305 1308
73. H.M. Felon, D.B. McAneny, and D.P. Nunes Occlusive colon carcinoma: virtual colonoscopy in the preoperative evaluation of the proximal colon Radiology 210 1999 423 428
74. S. Rubin Intestinal obstruction in advanced ovarian cancer: what does the patient want? Gynecol Oncol 75 1999 311 312
75. S.K. Joishy, and D. Walsh The opioid-sparing effects of intravenous ketorolac as an adjuvant analgesic in cancer pain: application in bone metastases and the opioid bowel syndrome J Pain Symptom Manage 16 5 1998 334 339
76. J.Y. Chen, G.J. Wu, and M.S. Mok Effect of adding ketorolac to intravenous morphine patient-controlled analgesia on bowel function in colorectal surgery patients - a prospective, randomized, double-blind study Acta Anaesthesiol Scand 49 4 2005 546 551
77. M.P. Davis, and A. Furste Glycopyrrolate: a useful drug in the palliation of mechanical bowel obstruction J Pain Symptom Manage 18 3 1999 153 154
78. M.P. Davis, and C. Nouneh Modern management of cancer-related intestinal obstruction Curr Oncol Rep 2 2000 343 350
79. C. Ripamonti, F. De Conno, and B.V. Ventafridda Management of bowel obstruction in advanced and terminal cancer patients Ann Oncol 4 1993 15 21
80. R.L. Fainsinger, T. MacEachern, and M.J. Miller The use of hypodermoclysis for rehydration in terminally ill cancer patients J Pain Symptom Manage 9 5 1994 298 302
81. N. Steiner, and E. Bruera Methods of hydration in palliative care patients J Palliat Care 14 2 1998 6 13
82. T. Morita, Y. Tei, and S. Inoue Fluid status of terminally ill cancer patients with intestinal obstruction: an exploratory observational study Support Care Cancer 10 2002 474 479
83. H.S. Pandha, and J. Waxman Octreotide in malignant intestinal obstruction Anticancer Drugs 7 1996 5 10
84. K. Mystakidou, E. Tsilika, and O. Kalaidopoulou Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double-blind, controlled clinical trial Anticancer Res 22 2002 1187 1192
85. S. Mercadante, and S. Maddaloni Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients J Pain Symptom Manage 7 8 1992 496 498
86. S. Mercadante, E. Spoldi, and A. Caraceni Octreotide in relieving gastrointestinal symptoms due to bowel obstruction Palliat Med 7 1993 295 299
87. H. Oishi, H. Shindo, and N. Shirotani The experience of improved quality of life at home for the long term, using percutaneous trans-esophageal gastro-tubing drainage for a case with terminal stage cancer J Tokyo Wom Med Univ 71 3 2001 188 192
88. H. Oishi, H. Shindo, and N. Shirotani A nonsurgical technique to create an esophagostomy for difficult cases of percutaneous endoscopic gastrostomy Surg Endosc 17 2003 1224 1227